ACA Foundation Awards Pharmacists Mutual Scholarship to ACA Student Pharmacist Members
Bartlett, TN., December 15, 2023: The American College of Apothecaries Research and Education Foundation announced that student pharmacists Camila Caban, Rachel Blanchard, Holly Seyler, and Alexandria Arnett have been awarded the Pharmacists Mutual | ACA Foundation Community Pharmacy Scholarship.
Pharmacists Mutual Insurance Company (www.phmic.com) donated funds to the American College of Apothecaries Research and Education Foundation to create the Pharmacists Mutual | ACA Foundation Community Pharmacy Scholarship. These scholarships are awarded to student pharmacists who have demonstrated academic excellence and a commitment to advancing the future of community pharmacy in the United States.
The American College of Apothecaries is proud to recognize their Student Pharmacist members Holly Seyler, Alexandria Arnett & Camila Caban with the Pharmacists Mutual | ACA Foundation Community Pharmacy Scholarship 2023!
Pharmacists Mutual | ACA Foundation Community Pharmacy Scholarship Award Winners Holly Seyler, Alexandria Arnett & Camila Caban.
Holly Seyler (PharmD Candidate 2025) from the University of Washington, a student member of the American College of Apothecaries (ACA) and the National Community Pharmacist Association (NCPA), Holly focuses on the importance of political advocacy for patient choice and access. Holly willingly advocates for the compounding pharmacy profession and volunteered her time as a teaching assistant for the UW Pharmaceutics Compounding Lab Course in Seattle, WA. Her leadership and commitment have contributed positively to the future of compounding pharmacy.
Holly is currently a Pharmacist Intern at Clark’s Compounding Pharmacy in Bellevue, WA where she continues to distinguish herself as a leader in the pharmacy community and devotes her life to patient-centered healthcare.
Alexandria Arnett (PharmD Candidate 2025) from Texas Tech University Health Sciences Center, a student pharmacist member of the American College of Veterinary Pharmacists (ACVP) and the American College of Apothecaries (ACA), Alexandria focuses on advancing community pharmacy patient care, compounding specific practicing, veterinary care, and the laws and regulations surrounding each of these aspects. Alexandria would like to see a growth in specialized compounding practices like cancer, diabetes, or pediatric compounding to allow for an increase in awareness for a patient care aspect that exists but is not as focused on, which would allow a variety of community pharmacies to provide increased patient-focused care. She is also interested in encouraging pharmacists to open more specialty independent pharmacies so patients can have access to specific medical therapies anywhere, including the veterinary world. Alexandria would like to push for at least one veterinary course to be taught at each pharmacy school to allow growth in compounding, which can drive more focus and funding to the specialty.
Alexandria is currently a Student Board Member of the American College of Veterinary Pharmacists (ACVP), President of Kappa Psi, and President of NCPA. In these roles, she has been responsible for organizing events, managing budgets, and coordinating educational opportunities. Her strong organizational skills, attention to detail, and ability to communicate effectively with others have made her a valuable member of these organizations.
Camila Hernandez Caban (PharmD Candidate 2025) from the University of Puerto Rico Medical Science Campus, a student member of the American College of Apothecaries (ACA), Academy of Student Pharmacist, and President of the American Pharmacist Association UPR Chapter, Camila’s goal is to introduce a psychosocial approach to community pharmacy. She collaborates with Professors in the Ethics and Culture course at the University of Puerto Rico where she impacts first and second-year students on public health and bioethical principles in providing quality care.
Camila is currently taking a pharmacogenomics elective and working on a business plan that uses this technology to optimize opioid therapy while incorporating harm-reduction strategies. She is involved in a research project on the physical stability of extemporaneous suspensions in the pediatric population of Puerto Rico, contributing to the literature on compounding and the applicability of U.S. quality standards.
